1. Breast cancer detection among Irish BRCA1 & BRCA2 mutation carriers: a population-based study. (February 2016) Authors: Walsh, E.; Farrell, M.; Nolan, C.; Gallagher, F.; Clarke, R.; McCaffrey, J.; Kennedy, M.; Barry, M.; Kell, M.; Gallagher, D. Journal: Irish journal of medical science Issue: Volume 185:Number 1(2016) Page Start: 189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinicopathologic significance of androgen receptor expression in invasive breast cancer: A comprehensive analysis in large cohorts. (July 2016) Authors: Aleskandarany, M.A.; Abduljabbar, R.; Sonbul, S.; Lai, C.F.; Ali, S.; Diez-Rodriguez, M.; Nolan, C.; Green, A.R.; Ellis, I.O.; Rakha, E.A. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Improving public health competencies through required practice experience. (November 2016) Authors: Steigerwald, D.; Nolan, C.; Loux, T.; Baskin, C.R.; Scharff, D.P. Journal: Public health Issue: Volume 140(2016) Page Start: 265 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP25.11: Rates of stillbirth and neonatal death secondary to IUGR over a 10‐year period. (September 2014) Authors: Nolan, C.; Kent, E. Journal: Ultrasound in obstetrics & gynecology Issue: Volume 44:Number 1(2014:Jul.) Page Start: 124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The reporting of research ethics committee approval and informed consent in otolaryngology journals. (February 2015) Authors: Murphy, S.; Nolan, C.; O'Rourke, C.; Fenton, J.E. Journal: Clinical otolaryngology Issue: Volume 40:Number 1(2015:Feb.) Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. VENETOCLAX (VEN), BENDAMUSTINE (B) AND RITUXIMAB (R) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) NON‐HODGKIN LYMPHOMA (NHL): FINAL RESULTS OF a PHASE I STUDY. (June 2017) Authors: Swinnen, L.J.; Flowers, C.R.; Wang, D.; Reid, E.; Fowler, N.; Cordero, J.; Dunbar, M.; Enschede, S.; Nolan, C.; Petrich, A.M.; Ross, J.; Salem, A.H.; Verdugo, M.; Wong, S.; Zhou, L.; Kozloff, M.; Nastoupil, L.; de Vos, S. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. YourTreatmentChoices: FAST ACCESS TO TRIALS PROGRAMME. (June 2017) Authors: Radford, J.; Gribben, J.; Johnson, P.W.; Malladi, R.; Neeson, S.; Asfaw, B.; O'Regan, L.; Law, A.; Ringrose, C.; Brownlow, R.; Jackson, A.; Nolan, C.; Nolan, C. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 272 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗